Gardenia Medical Services Limited 13918568 false 2022-02-16 2023-02-28 2023-02-28 The principal activity of the company is General medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true true 13918568 2022-02-16 2023-02-28 13918568 2023-02-28 13918568 bus:OrdinaryShareClass1 2023-02-28 13918568 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 13918568 core:OtherPropertyPlantEquipment 2023-02-28 13918568 bus:SmallEntities 2022-02-16 2023-02-28 13918568 bus:AuditExemptWithAccountantsReport 2022-02-16 2023-02-28 13918568 bus:AbridgedAccounts 2022-02-16 2023-02-28 13918568 bus:SmallCompaniesRegimeForAccounts 2022-02-16 2023-02-28 13918568 bus:RegisteredOffice 2022-02-16 2023-02-28 13918568 bus:CompanySecretaryDirector1 2022-02-16 2023-02-28 13918568 bus:OrdinaryShareClass1 2022-02-16 2023-02-28 13918568 bus:PrivateLimitedCompanyLtd 2022-02-16 2023-02-28 13918568 core:OtherPropertyPlantEquipment 2022-02-16 2023-02-28 13918568 core:PlantMachinery 2022-02-16 2023-02-28 13918568 countries:England 2022-02-16 2023-02-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13918568

Gardenia Medical Services Limited

Unaudited Filleted Abridged Financial Statements

for the Period from 16 February 2022 to 28 February 2023

 

Gardenia Medical Services Limited

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 6

 

Gardenia Medical Services Limited

Company Information

Director

Dr Tahsin Al-Mukhtar

Company secretary

Dr Tahsin Al-Mukhtar

Registered office

Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

Accountants

Charles Rippin and Turner Limited
Charles Rippin & Turner
Middlesex House
130 College Road
HA1 1BQ

 

Gardenia Medical Services Limited

(Registration number: 13918568)
Abridged Balance Sheet as at 28 February 2023

Note

2023
£

Fixed assets

 

Tangible assets

4

161,998

Current assets

 

Cash at bank and in hand

 

11,665

Creditors: Amounts falling due within one year

(20,855)

Net current liabilities

 

(9,190)

Total assets less current liabilities

 

152,808

Accruals and deferred income

 

(4,000)

Net assets

 

148,808

Capital and reserves

 

Called up share capital

6

1

Retained earnings

148,807

Shareholders' funds

 

148,808

For the financial period ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 21 October 2023
 

.........................................
Dr Tahsin Al-Mukhtar
Company secretary and director

 

Gardenia Medical Services Limited

Notes to the Unaudited Abridged Financial Statements for the Period from 16 February 2022 to 28 February 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

These financial statements were authorised for issue by the director on 21 October 2023.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Gardenia Medical Services Limited

Notes to the Unaudited Abridged Financial Statements for the Period from 16 February 2022 to 28 February 2023

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% Reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

 

Gardenia Medical Services Limited

Notes to the Unaudited Abridged Financial Statements for the Period from 16 February 2022 to 28 February 2023

4

Tangible assets

Other tangible assets
£

Total
£

Cost or valuation

Additions

185,109

185,109

At 28 February 2023

185,109

185,109

Depreciation

Charge for the period

23,111

23,111

At 28 February 2023

23,111

23,111

Carrying amount

At 28 February 2023

161,998

161,998

5

Debtors

Debtors includes £Nil due after more than one year.

6

Share capital

Allotted, called up and fully paid shares

 

2023

 

No.

£

Ordinary shares of £1 each

1

1

     

7

Dividends

Final dividends paid

Interim dividends paid

   

2023
£

 

Interim dividend of £2,000.00 per each Ordinary shares

 

2,000

 
       

Interim dividends paid

   

2023
£

 

Interim dividend of £2,000 per each Ordinary shares

 

2,000

 
       

Recommended final dividends paid and not recognised in the accounts

The director is recommending the following final dividends:

 

Gardenia Medical Services Limited

Notes to the Unaudited Abridged Financial Statements for the Period from 16 February 2022 to 28 February 2023

These dividends have not been accrued in the balance sheet.